Literature DB >> 8008199

Heterogeneity of evoked dopamine overflow within the striatal and striatoamygdaloid regions.

P A Garris1, E L Ciolkowski, R M Wightman.   

Abstract

The heterogeneity of evoked dopamine overflow in vivo was examined and compared in striatal and striatoamygdaloid regions of the rat. The characteristics of appearance and disappearance rates and the maximum concentration elicited were determined from overflow curves measured by fast-scan cyclic voltammetry. Overall, the characteristics of evoked dopamine overflow were quite variable in the striatum compared to the relative uniformity of overflow in the basolateral amygdaloid nucleus. In addition, there was a significant decrease in the extracellular disappearance rate of evoked dopamine with depth in the striatum. This gradient did not alter with passage from the caudate-putamen to the nucleus accumbens and no change was observed for the appearance rate or maximum concentration. In contrast, differences in evoked dopamine overflow within the striatoamygdaloid region were sharply defined dorsoventrally and appeared to be region-specific. Dopamine terminal fields in the striatum are not clearly demarcated into the caudate-putamen and nucleus accumbens, but may exist as a continuum. The uptake of dopamine appears to be the distinguishing characteristic for the regulation of extracellular dopamine levels in the striatum and the basolateral amygdaloid nucleus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008199     DOI: 10.1016/0306-4522(94)90606-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

1.  Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.

Authors:  Q Wu; M E Reith; M J Kuhar; F I Carroll; P A Garris
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

2.  Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo.

Authors:  F Gonon
Journal:  J Neurosci       Date:  1997-08-01       Impact factor: 6.167

3.  Implantable microelectrode arrays for simultaneous electrophysiological and neurochemical recordings.

Authors:  Matthew D Johnson; Robert K Franklin; Matthew D Gibson; Richard B Brown; Daryl R Kipke
Journal:  J Neurosci Methods       Date:  2008-07-23       Impact factor: 2.390

Review 4.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

5.  Extracellular dopamine levels in striatal subregions track shifts in motivation and response cost during instrumental conditioning.

Authors:  Sean B Ostlund; Kate M Wassum; Niall P Murphy; Bernard W Balleine; Nigel T Maidment
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

6.  Effects of intermittent and continuous cocaine administration on dopamine release and uptake regulation in the striatum: in vitro voltammetric assessment.

Authors:  S R Jones; T H Lee; R M Wightman; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

7.  Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.

Authors:  Christopher D Howard; Kristen A Keefe; Paul A Garris; David P Daberkow
Journal:  J Neurochem       Date:  2011-07-01       Impact factor: 5.372

8.  Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontophoresis in striatum.

Authors:  C Nicholson
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

Review 9.  A comparison of the subsecond dynamics of neurotransmission of dopamine and serotonin.

Authors:  Katie A Jennings
Journal:  ACS Chem Neurosci       Date:  2013-04-29       Impact factor: 4.418

10.  Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma.

Authors:  Peter M Bungay; Paige Newton-Vinson; Wanda Isele; Paul A Garris; Joseph B Justice
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.